State-of-the-Art Gynecologic Surgery & Ovarian Cancer Management Conference 2018

Advances in gynecologic surgery and women’s health research provide important opportunities to enhance women’s gynecologic health as well as the prevention and treatment of ovarian cancer. New modalities in the management of the disease provide the ability to individualize therapy, accomplish best clinical outcomes, and optimize the patient experience. This course is designed to present the most current information on gynecologic surgery and ovarian cancer with the goal of advancing the gynecologic outcomes, and the prevention and treatment for ovarian cancer.

This course is intended for OB/GYNs, medical and surgical oncologists, gynecologic oncologists, radiologists, pathologists, geneticists, primary care physicians, physician assistants, nurse practitioners, nurses, fellows, residents, scientists and other healthcare professionals interested in women’s health, and in optimizing the prevention and treatment for ovarian cancer.

1. Discuss advances in gynecologic surgery including methods to reduce surgical site infection, length of stay, DVT, and perioperative pain management.
2. Present options for minimally invasive gynecologic surgery in the management of the adnexal mass and risk-reducing procedures.
3. Present state of the art strategies for the medical and surgical management of primary and recurrent ovarian cancer.
4. Evaluate emerging opportunities in clinical trial options, individualized treatment, and enhanced patient experience.

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

• 30% Discounted Rate for MSK Alumni and MSK Alliance Members - MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for more information or to register.
• MSK Staff Registration - Registration is complimentary for MSK staff who wish to attend this course. However, you must complete course registration to attend this course.

After your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course ([email protected]).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

MSK Course Directors

Ginger J. Gardner, MD
Associate Attending Surgeon,
Physician Lead, Gynecology Disease Management Team Alliance,
Gynecology Service,
Section of Ovarian Cancer Surgery

Kara Long Roche, MD, MSc
Assistant Attending Surgeon,
Gynecology Service,
Section of Ovarian Cancer Surgery

MSK Course Faculty

Nadeem Abu-Rustum, MD
Chief, Gynecology Service
Vice Chair for Technology Development, 
Department of Surgery
Avon Chair in Gynecologic Oncology 

Anoushka M. Afonso, MD
Director, Enhanced Recovery after Surgery (ERAS) 
Assistant Attending, 
Department of Anesthesiology and Critical Care

Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service

Carol Brown, MD
Director, Office of Diversity Programs in Clinical Care, Research, and Training,
Attending Surgeon, Gynecology Service, 
Department of Surgery

Jeanne Carter, PhD
Head, Female Sexual Medicine
Associate Attending Psychologist 

Dennis S. Chi, MD
Deputy Chief and Head, Section of Ovarian Cancer Surgery, 
Attending Surgeon, Gynecology Service,
Department of Surgery

Claire Friedman, MD
Assistant Attending Physician, 
Gynecologic Medical Oncology Service 

Deborah Goldfrank, MD
Head, General Gynecology

Rachel Grisham, MD
Assistant Attending,
Gynecologic Medical Oncology Service

Amitabh Gulati, MD
Director, Chronic Pain,
Department of Anesthesiology and Critical Care 

Martee Hensley, MD
Attending Physician, 
Gynecologic Medical Oncology Service 

Yuliya Lakhman, MD
Associate Attending, Department of Radiology

Mario M. Leitao, Jr., MD
Attending Surgeon, Gynecology Service
Director, Minimal Access and Robotic Surgery Program,
Department of Surgery 

Jennifer Mueller, MD
Assistant Attending Surgeon, 
Gynecology Service

Roisin E. O’Cearbhaill, MD
Assistant Attending Physician, 
Gynecologic Medical Oncology Service  

Rekha Parameswaran, MD
Associate Attending Physician, 
Hematology Service

Paul Sabbatini, MD
Deputy Physician-in-Chief for Clinical Research, Attending Physician, 
Gynecologic Medical Oncology Service 

Yukio Sonoda, MD
Attending Surgeon, Gynecology Service,
Section of Ovarian Cancer Surgery 

William P. Tew, MD
Clinical Director, Associate Attending Physician, 
Gynecologic Medical Oncology Service 

Harini Veeraraghavan, PhD
Assistant Attending,
Department of Medical Physics

Dmitriy Zamarin, MD, PhD
Assistant Attending Physician, 
Gynecologic Medical Oncology Service 

Oliver Zivanovic, MD, PhD
Director, Innovative Surgical Technology, 
Attending Surgeon, Gynecology Service, 
Department of Surgery, Section of Ovarian Cancer Surgery 

Invited Course Faculty

Giovanni D. Aletti, MD
Director, Innovative Therapeutic Strategies in Ovarian Cancer
European Institute of Oncology
University of Milan
Milan, Italy

William Cliby, MD
Professor, Division of Gynecologic Oncology, 
Department of Obstetrics and Gynecology
Mayo Clinic
Rochester, MN

Elizabeth Fino, MD
Assistant Professor, 
Reproductive Endocrinology, 
Department of Obsterics and Gynecology, New York University
New York, NY

Nicole Fleming, MD
Associate Professor, 
Department of Gynecologic Oncology, 
MD Anderson Cancer Center
Houston, TX

Martin Martino, MD
Division of Gynecologic Oncology, 
Department of Obstetrics and Gynecology, 
Lehigh Valley Physician Group
Allentown, PA

Farr Nezhat, MD
Clinical Professor, Weill Cornell Medical College of Cornell University,
Director of Minimally Invasive Surgery, 
NYU Winthrop Hospital
New York, NY

Juliet Wolford, MD
Division of Gynecologic Oncology,
University of California, Irvine
Irvine, CA

Faculty Disclosures (All Faculty)

Thursday, October 4, 2018

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing independent medical educational grants or financial support for this live activity:

• AstraZeneca
• Ethicon
• Intuitive Surgical, Inc.
• Medtronic
• Merck
• ThermaSolutions, Inc.